Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer

door Heerma van Voss, Marise R., Brilliant, Justin D., Vesuna, Farhad, Bol, Guus M., van der Wall, Elsken, van Diest, Paul J., Raman, Venu
Gepubliceerd in Med Oncol (2017)

Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach

door Heerma van Voss, Marise R., Kammers, Kai, Vesuna, Farhad, Brilliant, Justin, Bergman, Yehudit, Tantravedi, Saritha, Wu, Xinyan, Cole, Robert N., Holland, Andrew, van Diest, Paul J., Raman, Venu
Gepubliceerd in Transl Oncol (2018)

Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer

door van Voss, Marise R. Heerma, Vesuna, Farhad, Trumpi, Kari, Brilliant, Justin, Berlinicke, Cynthia, de Leng, Wendy, Kranenburg, Onno, Offerhaus, Johan G., Bürger, Horst, van der Wall, Elsken, van Diest, Paul J., Raman, Venu
Gepubliceerd in Oncotarget (2015)